tirzepatide vs semaglutide compound caused roughly half as many patients to stop treatment because of gastrointestinal side effects as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide compounded semaglutide tirzepatide reliable sources

As a multi-pathway incretin agonist, Retatrutide shows promise in enhancing energy expenditure and insulin sensitivity while promoting weight control and fat reduction

Eur J Pharmacol, 1999

[64], which involved a co-culture of primary astrocytes with the bEnd.3 endothelial cell line, incubation with exendin-4 reduced the levels of the astrocyte-derived vascular endothelial growth factor (VEGF-A), matrix metalloproteinase-9 (MMP-9), chemokine monocyte chemoattractant protein-1 (MCP-1), and the chemokine C-X-C motif ligand 1 (CXCL-1), induced by oxygenglucose deprivation (OGD), and subsequently led to the increased expression of tight junction proteins in the bEnd.3 cells

GLP-1 drugs like Mounjaro, Ozempic and Wegovy, have surged in popularity because of their effectiveness

Here is how to assess and respond

Work with a dietitian if possible to ensure your carbohydrate intake is appropriate and consistent